On August 25, Centrus rose 8.06% in regular trading, trading at $191.26/share, with turnover of $60.26 million. The stock rallied alongside broad-based strength in the uranium sector, driven by ongoing concerns over global nuclear fuel supply chain tightening.
The uranium enrichment market continues to face structural supply constraints, with international spot prices surging from approximately $34 per separative work unit in 2018 to around $200 recently — nearly a sixfold increase. The US ban on Russian enriched uranium imports effective from 2028, combined with rising electricity demand from AI data centers and global nuclear expansion programs, has intensified pressure on Western enrichment capacity. Russia's state atomic energy company accounts for over 40% of global uranium enrichment capacity, channeling new demand toward a limited number of alternative suppliers.
Recent analyst actions have supported sentiment, with Barclays initiating coverage at Equalweight with a $207 price target and UBS raising its target to $185 from $170. The company also reported strong Q2 results earlier this month, with adjusted EPS of $1.77 significantly beating the $0.77 consensus estimate, and revenue of $176.1 million exceeding expectations.
Within the Coal and Consumable Fuels sector, Energy Fuels rose 8.67%, Denison Mines rose 7.77%, Uranium Energy rose 7.55%, Cameco rose 5.27%, and Nexgen Energy rose 3.43%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments